Admiral Technology
Empowering clinical diagnostics through advanced molecular recognition and automatic chromatography mass spectrometry.
Empowering clinical diagnostics through advanced molecular recognition and automatic chromatography mass spectrometry.
Admiral Technology is a private enterprise specializing in technology, founded in 2022. The company's slogan, "Empowering clinical diagnostics through advanced molecular recognition and automatic chromatography mass spectrometry," underscores its focus on the research and development, production, and sales of clinical diagnostic application products. These products utilize molecular recognition technology and automatic chromatography mass spectrometry system detection. Admiral Technology offers a range of innovative solutions including a fully automatic therapeutic drug monitoring and analysis system, fully automatic online extraction, a TDM special kit, and quality control. The company's venture round on 06 January 2023 secured investment from Nanjing Innovation Capital Group and Zijin High-Tech Venture Capital. With its primary focus on the Biotechnology and Pharmaceutical industries, Admiral Technology presents an exciting prospect for investors seeking opportunities in advanced clinical diagnostic technologies.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 2 |
|
06 Jan 2023 |
No recent news or press coverage available for Admiral Technology.
We care about your data, and we'd love to use cookies make your experience better.
